Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ironwood Pharmaceuticals Inc (IRWD)  
$6.52 0.32 (5.16%) as of 4:30 Fri 6/28


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 173,744,000
Market Cap: 1.13(B)
Last Volume: 148,509 Avg Vol: 0
52 Week Range: $5.58 - $15.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 8.3
Insider 3/6 Months : 8.9
Guru Rank Number :  607
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focusing on developing the treatment of GI diseases. LINZESS® (linaclotide), Co.'s commercial product, is a product in a class of GI medicines called guanylate cyclase type C agonists and is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is available to adult men and women suffering from IBS-C or CIC in the U.S. and Mexico and to adult men and women suffering from IBS-C in Japan and China. Co. has partnerships with pharmaceutical companies to support the development and commercialization of linaclotide.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 17,604 53,676 53,676
Total Buy Value $0 $160,420 $460,539 $460,539
Total People Bought 0 2 2 2
Total Buy Transactions 0 2 3 3
Total Shares Sold 226,641 507,557 529,791 1,205,966
Total Sell Value $1,459,885 $5,741,044 $5,974,538 $13,645,593
Total People Sold 6 7 8 11
Total Sell Transactions 7 12 16 50
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 931
  Page 23 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Conrades George N Director   –       •      –    2015-02-17 4 D $0.00 $0 I/I (254,152) 0     -
   Cook Joseph C Jr Director   –       •      –    2014-12-26 4 GD $0.00 $0 D/D 7,800 82,075     -
   Higgins Michael J Chief Operating Officer   •       –      –    2014-12-23 4 OE $1.56 $45,399 D/D 29,102 329,102     -
   Cook Joseph C Jr Director   –       •      –    2014-12-22 4 A $0.00 $0 D/D 19,200 306,163     -
   Cook Joseph C Jr Director   –       •      –    2014-12-22 4 GD $0.00 $0 D/D 32,400 325,363     -
   Cook Joseph C Jr Director   –       •      –    2014-12-22 4 A $0.00 $0 D/D 19,200 89,875     -
   Higgins Michael J Chief Operating Officer   •       –      –    2014-12-16 4 S $14.01 $223,978 D/D (15,987) 300,000     -
   Higgins Michael J Chief Operating Officer   •       –      –    2014-12-16 4 OE $2.94 $47,002 D/D 15,987 315,987     -
   Ebersman David A Director   –       •      –    2014-12-15 4 A $0.00 $0 D/D 182 29,549     -
   Walsh Christopher T Phd Director   –       •      –    2014-12-15 4 A $0.00 $0 D/D 182 29,549     -
   Roberts Bryan E Director   –       •      –    2014-12-15 4 A $13.70 $2,493 D/D 182 15,401     -
   Roberts Bryan E Director   –       •      –    2014-12-15 4 S $15.06 $18,072 I/I (1,200) 16,498     -
   Roberts Bryan E Director   –       •      –    2014-12-12 4 S $15.21 $282,784 I/I (18,592) 17,698     -
   Cook Joseph C Jr Director   –       •      –    2014-12-11 4 AS $15.00 $1,500 D/D (100) 80,675     -
   Higgins Michael J Chief Operating Officer   •       –      –    2014-11-24 4 S $13.75 $974,848 D/D (70,898) 300,000     -
   Higgins Michael J Chief Operating Officer   •       –      –    2014-11-24 4 OE $1.56 $110,601 D/D 70,898 370,898     -
   Currie Mark G Chief Scientific Officer   •       –      –    2014-11-13 4 AS $13.63 $272,600 D/D (20,000) 310,000     -
   Currie Mark G Chief Scientific Officer   •       –      –    2014-11-13 4 OE $0.60 $12,000 D/D 20,000 330,000     -
   Hecht Peter M Chief Executive Officer   •       •      –    2014-10-20 4 GA $0.00 $0 I/I 3,210 4,850     -
   Walsh Christopher T Phd Director   –       •      –    2014-09-15 4 A $0.00 $0 D/D 198 29,367     -
   Ebersman David A Director   –       •      –    2014-09-15 4 A $0.00 $0 D/D 198 29,367     -
   Roberts Bryan E Director   –       •      –    2014-09-15 4 A $12.59 $2,493 D/D 198 15,219     -
   Roberts Bryan E Director   –       •      –    2014-08-22 4 A $0.00 $0 I/I 1,955,994 36,290     -
   Roberts Bryan E Director   –       •      –    2014-08-22 4 A $0.00 $0 I/I 1,955,994 0     -
   Mcguire Terrance Director   –       •      –    2014-07-09 4 A $0.00 $0 I/I 29,117 29,117     -
  931 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 23 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us